Backing the next generation of Nottingham spin-outs: watch the University of Nottingham EIS Fund I webinar

Syndicate Room
Syndicate Room
October 6, 2026
•
2 min read

The University of Nottingham EIS Fund I lets individual investors back the university's spin-outs alongside the university itself. In this 50-minute webinar, Dr Alice MacGowan, CEO of Nottingham Technology Ventures, explains how the fund chooses companies, two spin-out founders describe their journeys, and Tom Britton sets out how the fund works.


What the webinar covers

The portfolio behind the fund.

Nottingham Technology Ventures, the university's venture arm since 2017, manages 44 companies and has created more than 30 in the past five to six years. Its companies have raised more than £100 million over the past five years. Alice also explains why spin-outs in the Midlands have long been underfunded compared with other UK regions.

The types of companies the fund will review. 

IP from the university with an evidence-based foundation, experienced technical and commercial leadership, and a market already asking for the technology. The target sectors are life sciences, cleantech, advanced manufacturing, AI and digital.

Rather than us trying to push our ideas up a hill, we're looking for opportunities where there's really strong market pull.
Dr Alice MacGowan|CEO, Nottingham Technology Ventures

A Q&A with mature portfolio spin-out: Scancell.

Professor Lindy Durrant, Chief Scientific Officer, describes taking cancer vaccine research from a university lab through phase one and phase two clinical trials, and what the university did to help along the way.

A Q&A with a new spin-out: HPDrive Technologies. 

Professor Henner Wapenhans, CEO, explains why a company launched with GKN Aerospace in July 2026 is building high-power electric drives for zero-emission flight on eight years of existing research.

Scancell and HPDrive Technologies appear as examples of the university's portfolio. Neither is a confirmed investment of the fund.

How the fund works.

SyndicateRoom Cofounder Tom Britton covered the fund's structure, the EIS reliefs, fees, how the timing of each investment affects carry back, and how to invest. The fund aims to back six to eight companies and to deploy across the 2026/27 and 2027/28 tax years. Tax treatment depends on individual circumstances and may change.

Questions from investors.

A number of questions from the audience.

The fund is open until the end of November 2026

The University of Nottingham EIS Fund I is provisionally due to close at the end of November 2026, and the minimum investment is £10,000. Read the information memorandum and key information document on the fund page before you decide whether to invest. If you have questions about the fund, email Tom Britton at tom@syndicateroom.com.

University of Nottingham EIS Fund I
Award
University of Nottingham EIS Fund I expects to invest in 6 to 8 spin-out companies from the University of Nottingham.

The minimum subscription is £10,000.
The next investment deadline is November 2026.

If you are unsure if this type of investment is suitable for you, consult a regulated independent financial adviser.


Related Articles
Article
Loading article title placeholder that wraps onto multiple lines
1 Jan 2026 • 10 min
Read article
Article
Loading article title placeholder that wraps onto multiple lines
1 Jan 2026 • 10 min
Read article
Article
Loading article title placeholder that wraps onto multiple lines
1 Jan 2026 • 10 min
Read article
About the author
Syndicate Room
Syndicate Room|
Syndicate Room is authorised and regulated by the Financial Conduct Authority.
Featured Articles
Risk warning: Please click here to read the full risk warning.
Investing in early-stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. Tax relief depends on an individual’s circumstances and may change in the future. In addition, the availability of tax relief depends on the company invested in maintaining its qualifying status. Past performance is not a reliable indicator of future performance. You should not rely on any past performance as a guarantee of future investment performance.
This page has been approved as a financial promotion by Syndicate Room Ltd, which is authorised and regulated by the Financial Conduct Authority (No. 613021).
We use cookies to improve our service. By continuing to use this site you are agreeing to their use. Find out more. .
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
General enquiries

Please note: our office hours are weekdays, 9.30am - 5.30pm.